babin

You're never too young to get an ulcer. The College Board is planning to roll out a new college assessment exam for eighth graders in 2010.

Marketplace's Janet Babin reports.

The Environmental Protection Agency denied Texas's request for a reduction in a federal ethanol mandate. Who gains and who loses from the decision?

Janet Babin reports.

The largest untapped oil source, enough to sustain U.S. demand for a century, may be right here at home in the Rocky Mountains.

But first, we have to find a way to get it out. Janet Babin reports.

General Motors is asking more than 30 utility firms to help deploy a network of recharging stations before the launch of its plug-in electric car in 2010.

Janet Babin reports.

Swiss pharmaceutical giant Roche says it wants to buy California-based Genentech, maker of three of the best-selling cancer drugs in America.

But Genentech's not going to come as cheap as Roche is hoping -- if the deal goes down at all. Janet Babin reports.

IBM, which had strong second-quarter earnings, is known as an indicator for the health of tech stocks. Then why did other tech giants fall flat?

Janet Babin has the story.

Anti-malarial drugs can be so expensive that people with the disease go untreated. Former President Bill Clinton's foundation has struck a deal that would limit the cost of the drugs.

Janet Babin reports.

Apple's latest iPhone launches Friday, but the real buzz is around a software update that will give iPhone users access to third party applications.

Janet Babin reports.

With landfill space at a premium, a machine that vaporizes trash into seems like a miracle. But does it send the wrong message in our disposable-loving economy?

Janet Babin reports.

It's got a big name -- bapineuzumab -- but a new Alzheimer's drug could also have a big payoff. With projections in the billions, it could be the highest grossing drug in history.

Janet Babin reports.